36 research outputs found
Hemorrhagic shock as a complication of anticoagulant therapy following the mitral valve replacement
This report describes a case of the hemorrhagic shock in a patient on the anticoagulant therapy supplementing implanted mechanical prosthetic heart valve replacing the mitral valve. The association between hemorrhagic shock, mechanical prosthetic heart valve and anticoagulant therapy is briefly discussed
Hemorrhagic shock as a complication of anticoagulant therapy following the mitral valve replacement
This report describes a case of the hemorrhagic shock in a patient on the anticoagulant therapy supplementing implanted mechanical prosthetic heart valve replacing the mitral valve. The association between hemorrhagic shock, mechanical prosthetic heart valve and anticoagulant therapy is briefly discussed
The Relationship between Prolonged Cerebral Oxygen Desaturation and Postoperative Outcome in Patients Undergoing Coronary Artery Bypass Grafting
58 patients who underwent on-pump coronary artery bypass graft surgery were evaluated for changes in regional cerebral
oxygen saturation (rSO2) measured by near infrared spectroscopy (NIRS). If rSO2 during the operation fell to
more than 20% under the baseline, standardized interventions were undertaken to maintain rSO2. Despite those interventions,
in some cases we observed inability to maintain rSO2 above this threshold. Therefore we divided patients in two
subgroups: 1. without prolonged rSO2 desaturation; 2. with prolonged rSO2 desaturation (area under the curve >150
min% for rSO250 min% for rSO2<50% of absolute value). The data were analyzed to determine
whether there were major differences in outcome of these two groups. 18 out of 58 patients (31%) had prolonged rSO2
desaturation during operation. There was significantly higher number of diabetic patients in group with prolonged rSO2
desaturation (p=0.02). Intraoperative data revealed significantly more blood consumption during cardiopulmonary bypass
(p=0.007) and the need for inotropes (p=0.04) in desaturation group. Three patients in prolonged desaturation
group and no one in another group had stroke, coma or stupor (p=0.03). Logistic regression analysis revealed diabetes
mellitus and age as predictors for prolonged rSO2 desaturation. We concluded that prolonged intraoperative rSO2 desaturation
is significantly associated with worse neurological outcome in patients ā nonresponders to standardized interventions
for prevention of rSO2 desaturation
BORA ON THE NORTHERN ADRIATIC COAST DURING THE ALPEX SOP 20-25 MARCH 1982
Results from investigation of the bora during the period of 20-25 March 1982 are characterized by a large variability od bora strength, direction and duration.
The two distinct wind speed maxima indicate two different origins of bora genesis. The first bora (21 March) was caused by a cold air stream, followed by the Genova cyclogenesis process. The second bora situation (23-25 March) is connected with the central Eyrope anticyclone and the cold NE flow - upstream of the Dinaric Alps.
Assuming that the bora has a certain similarity with the supercritical flows described by hydraulic theory, the parameters of the real flow could be successfully predicted on the entire northern Adriatic in the case with the strongest bora
Rezultati ugradnje Levitronix Centrimag mehaniÄke potpore srcu u KliniÄkom bolniÄkom centru Zagreb
Background: The management of end stage heart failure has been revolutionized by the use of mechanical circulatory support. The Levitronix Centrimag ventricular assist device (VAD) is designed for short-term cardiac assistance as a bridge to a more permanent solution to the hemodynamic problem. It has been used as bridge-to-transplantation, bridge-to-bridge, bridge-to-recovery, and bridge-to-decision. Methods: In the period between September 2008 and November 2009, six patients received mechanical cardiac assistance with the Levitronix Centrimag device at our institution. In one patient, the indication was postcardiotomy cardiogenic shock. In the remaining five patients, the device was implanted electively, due to progressive decompensation of chronic heart failure unresponsive to medical therapy. Results: The patient having received a biventricular assist device (BIVAD) in the postcardiotomy setting was 65 years of age. His ejection fraction and EuroSCORE were 20 % and 25, respectively. His NT-pro-BNP was 9,428 pg/ml and his pre-implantation lactate was 8.8 mmol/L. The mean age in the group of patients, in whom the VAD was placed due to decompensated severe heart failure (DSHF ), was 46 Ā± 11 years. Their ejection fraction and logistic EuroSCORE were 16 Ā± 2 % and 28 Ā± 7, respectively. The preoperative serum lactate and NT-pro-BNP concentrations were 1.7Ā±0.8 mmol/L and 9577 Ā± 3674 pg/ml, respectively. Of these, three patients had evidence of end organ dysfunction. The low cardiac output was responsible for acute renal failure, requiring renal replacement therapy in one patient. Neurocognitive dysfunction and renal failure not requiring dialysis was seen in another. The third patient had long standing primary hepatic insufficiency. A reversal of end organ dysfunction was seen in the former two patients, whereas the hepatic insufficiency was not caused by hemodynamic compromise and was, therefore, not relieved by circulatory support. The single patient, who had suffered from postcardiotomy cardiogenic shock, died shortly after receiving mechanical circulatory support. Three of five patients, in whom Levitronix Centrimag was placed electively, were successfully transplanted. The remaining two died of septic complications. In the cohort of patients, in whom ventricular assistance was placed due to DSHF , two required BIVAD placement, and three left ventricular assist devices (LVAD). Conclusion: The Levitronix Centrimag VAD is useful in supporting circulation in patients with acute decompensation of congestive heart failure. It may also be used in patients with postcardiotomy shock. It is an imperative for the device to be placed before irreversible organ dysfunction occurs as the aftermath of malperfusion.Uvod: LijeÄenje terminalne faze srÄanog popuÅ”tanja je revolucionarizirano uvoÄenjem mehaniÄke potpore srcu. Levitronix Centrimag je ureÄaj dizajniran u svrhu kratkoroÄne hemodinamske potpore prije nego Å”to trajnije rjeÅ”enje cirkulatornog problema postane moguÄe. Do sad se primijenjivao kao podrÅ”ka srcu do transplantacije srca, do oporavka srÄane funkcije ili do ugradnje trajnijeg oblika mehaniÄke potpore srcu. Metode: U periodu izmeÄu rujna 2008 i studenog 2009 Levitronix Centrimag je u naÅ”oj ustanovi ugraÄen u 6 bolesnika. U jednog bolesnika radilo se o postkardiotomijskom sindromu niskog minutnog volumena. U preostalih pet bolesnika ovaj je oblik mehaniÄke potpore srcu ugraÄen elektivno radi progresivnog kliniÄkog pogorÅ”anja bolesnika u terminalnoj fazi srÄanog popuÅ”tanja koje je postalo rezistentno na konzervativnu terapiju. Rezultati: Bolesnik u kojeg je indikacija za mehaniÄkom potporom srcu bila postavljena hitno u postkardiotomijskom srÄanom popuÅ”tanju bio je 65 godina star. Imao je ejekcijsku frakciju od 20% dok mu je logistiÄki EuroSCORE bio 25. Prijeoperacijski NT-pro-BNP bio je 9428 pg/ ml dok su serumske vrijednosti laktata prije implantacije Centrimaga bile 8.8 mmol/L. ProsjeÄna dob u skupini bolesnika u kojih je indikacija za mehaniÄku potporu srcu bila progresivna dekompenzacija srÄane funkcije bila je 46 Ā± 11 godinu. Navedeni bolesnici su imali prosjeÄnu ejekcijsku frakciju od 16 Ā± 2% dok im je logistiÄki EuroSCORE bio 28 Ā± 7. Prijeoperacijske vrijednosti serumskog laktata i NT-pro-BNP bile su 1.7Ā±0.8 mmol/L i 9577 Ā± 3674 pg/ml. U troje bolesnika bila je evidentna kompromitacija funkcije nekog od ostalih organskih sustava. U jednog bolesnika se radilo o akutnom renalnom zatajenju ovisnog o hemodijalizi, u drugog o neurokognitivnoj disfunkciji praÄenog sa bubrežnim zatajenjem ali bez potrebe za dijalizom. U treÄeg bolesnika radilo se o primarnoj hepatalnoj insuficijenciji. U prva dva bolesnika doÅ”lo je do poboljÅ”anja organskih funkcija nakon uspostave mehaniÄke potpore srcu, dok u treÄeg bolesnika nije doÅ”lo do promjene hepatalne funkcije buduÄi da ista nije bila uzrokovana malperfuzijom. Bolesnik u kojeg je mehaniÄka potpora srcu stavljena zbog postkardiotomijskog kardiogenog Å”oka je umro. Troje od pet bolesnika kod kojih je Levitronix Centrimag ugraÄen radi dekompenzacije kroniÄnog zatajenja srca su uspjeÅ”no transplantirani. Preostalo dvoje bolesnika je umrlo od septiÄnih komplikacija. U kohorti bolesnika u kojoj je mehaniÄka potpora srcu ugraÄena elektivno, dvoje bolesnika je zahtijevalo potporu oba ventrikula dok je u troje ugraÄena potpora samo lijevom. ZakljuÄak: Levitronix Centrimag pruža efikasnu hemodinamsku potporu bolesnicima sa kompromitiranom srÄanom funkcijom. Neophodno je zapoÄeti sa mehaniÄkom potporom srcu prije nego Å”to se pojave ireverzibilne disfunkcije ostalih organskih sustava
PREOPERATIVE ANAESTHESIOLOGIC EVALUATION OF PATIENT WITH KNOWN ALLERGY
Anaphylaxis is an unanticipated systemic hypersensitivity rea ction which can produce deleterious effects, even death, if not
treated promptly. Preventive approach implies taking a thorough anamnesis with the emphasis on previously diagnosed allergies. If
an allergic reaction occurred during previous surgery, a detailed documentation of administered anaesthetic agents and drugs would
be crucial for the following anaesthesiologic management. Preoperative planning and avoiding cross-reactivity with drugs
commonly used during anaesthesia are the key points to prevent an anaphylaxis. In case of emergency surgery when the exact
identification of allergens is not possible, premedication prophylaxis should be considered. General measures for prevention of
anaphylaxis could be undertaken as well, such as the choice of anaesthesiologic drugs and techniques in the operating theatre
adequately equipped for the management of predictable anaphylaxis
Anesthesia management of a patient with heart transplant for non-cardiac surgery ā case report and literature review
Od prve transplantacije srca 1967. u svijetu se na godinu izvede oko 3500 novih transplantacija srca, uz prosjeÄno posttransplantacijsko preživljenje od 15 godina. Danas je sve ÄeÅ”Äe da skupina pacijenata s transplantiranim srcem bude podvrgnuta nekardijalnim operacijama, Å”to je novi izazov za anestezioloÅ”ko zbrinjavanje zbog patofizioloÅ”kih i farmakoloÅ”kih interakcija s denerviranim presatkom srca, nuspojava imunosupresivne terapije, rizika od infekcije i odbacivanja transplantata. U ovom prikazu pacijentici s transplantiranim srcem potpuno
je uklonjena Å”titnjaÄa (tiroidektomija) zbog papilarnog karcinoma Å”titnjaÄe. Pacijentica je bila I. kategorije prema klasifikaciji NYHA-e (New York Heart Association) i III. kategorije prema klasifikaciji ASA-e (American Society of Anesthesiologists), uz urednu funkciju alopresatka i stabilan sinusni ritam. Zahvat je izveden u opÄoj endotrahealnoj anesteziji. Neuromuskularni blok prekinut je sugamadeksom (BridionĀ®, Merck) i bolesnica je otpuÅ”tena kuÄi nakon 3 dana.Since the first human cardiac transplantation in 1967, approximately 3,500 heart transplants are performed every year in the world and post-operation survival period average is 15 years. Due to these facts
these patients are now presenting for various non-cardiac procedures. The information regarding the physiological and pharmacological interactions in a denervated allograft heart, the side-effects of immunosuppression, the risk of infection, and the potential for rejection is essential for anesthetic management. This case report reviews the anesthetic management of a heart transplant recipient undergoing a total thyroidectomy. She was NYHA I, ASA grade III with normal alograft function and sinus rhythm. Anesthesia was performed in general endotracheal anesthesia. Neuromuscular block was reversed with sugammadex and she was discharged after three days